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Abstract. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a minimally invasive imaging
technique which can be used for characterizing tumor biology and tumor response to radiotherapy. Pharmacokinetic
(PK) estimation is widely used for DCE-MRI data analysis to extract quantitative parameters relating to microvascu-
lature characteristics of the cancerous tissues. Unavoidable noise corruption during DCE-MRI data acquisition has a
large effect on the accuracy of PK estimation. In this paper, we propose a general denoising paradigm called gather-
noise attenuation and reduce (GNR) and a novel temporal-spatial collaborative filtering (TSCF) denoising technique
for DCE-MRI data. TSCF takes advantage of temporal correlation in DCE-MRI, as well as anatomical spatial similar-
ity to collaboratively filter noisy DCE-MRI data. The proposed TSCF denoising algorithm decreases the PK parameter
normalized estimation error by 57% and improves the structural similarity of PK parameter estimation by 86% com-
pared to baseline without denoising, while being an order of magnitude faster than state-of-the-art denoising methods.
TSCF improves the univariate linear regression (ULR) c-statistic value for early prediction of pathologic response up
to 18%, and shows complete separation of pathologic complete response (pCR) and non-pCR groups on a challenge
dataset.
Keywords: dynamic contrast-enhanced MRI, pharmacokinetic analysis, response prediction, breast cancer, Tofts
model, denoising, collaborative filtering.
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1 Introduction
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a well established method
for measuring changes in microvascular properties associated with diseased tissues in order to char-
acterize tissue biology.1–15 Typically, a bolus of a diffusible contrast agent (CA) is injected and
the physiological information is estimated by the pharmacokinetic (PK) model, usually a compart-
mental model describing the rate of transfer of contrast agent between blood pool and extravascu-
lar extracellular space (EES). With the modern fast sequences DCE-MRI can provide very good
temporal and spatial resolution along with good organ coverage6 and hence DCE-MRI becomes
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(a) DRO v9 ground truth signals. (b) DRO v9 noisy signals.
Fig 1: DCE-MRI signals with and without noise (Ktrans = 0.01). Values shown in the figure are
pre-contrast signal intensity. Data is digital reference object (DRO) data from Duke University.
a promising minimally invasive imaging technique to characterize tumor biology and tumor re-
sponse to radiotherapy.16 The recommended kinetic parameters of interest17–19 in anti-angiogenic
and anti-vascular therapies are usually Ktrans, the transfer constant of the CA, and ve, the volume
fraction of EES.
Adoption of DCE-MRI into widespread clinical use requires accurate estimation and good re-
producibility of the pharmacokinetic parameters. Although the parameters estimated from pharma-
cokinetic modeling of DCE-MRI data sequence should in theory be independent of data acquisition
platforms and techniques, the accurate estimation of these parameters is influenced by many fac-
tors, such as choice of arterial input functions (AIF or the concentration of CA in the blood pool as
a function of time),20–25 quantification of pre-contrast relaxation rate R1,21, 26–29 selection of model
and techniques for precise parameter estimation using the selected model to fit the data,18,30–33 and
the signal-to-noise ratio (SNR).28,34–41
This paper focuses on the inaccuracies in the estimation of kinectic parameters due to unavoid-
able noise corruption at the DCE-MRI data acquisition step and proposes methods and algorithms
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to handle such scenarios. The MRI raw data is measured through a quadrature detector resulting
in the real and the imaginary quadrature channels each separately corrupted with white additive
noise. Taking the magnitude of the complex data (Rician distribution) results in a nonlinear map-
ping between the noisy and the true unknown signal rendering the noise non-additive. Hence one
of the key challenges in denoising MR data corrupted with Rician noise is heteroskedasticity (i.e.,
the standard-deviation of the noise corrupted magnitude signal is not uniform across the entire
image but depends on the unknown true signal itself). As the PK parameter estimation is directly
dependent on the signal intensity (Pharmacokinetic and MRI model, appendix), the noise distorted
signal has direct implications on the accuracy of the estimated parameters, and thereby the char-
acterization of the tissue biology. Figure 1 shows how MRI acquisition noise can adversely affect
the intensity of DCE-MRI data, and thus affect the accuracy of PK parameters estimation.
To address the above mentioned challenges in noise corrupted MRI data, several denoising
schemes have previously been proposed to estimate the true signal from the raw magnitude MRI
signal. Many of them are maximum-likelihood estimation (MLE) based methods for simultaneous
noise variance and signal intensity estimation fromMRmagnitude imaging.36–39 However, because
such approaches require nonlinear optimization of a 2D function at each voxel, they come with a
high computational cost. Another approach involves calculation of an unbiased estimator of the
signal intensity that depends on the second moment of the magnitude signal.40,41 However, this
works on the assumption that the noise variance is known a priori, which might not be realistic
in a real world scenario. Koay et al.34 proposed a fixed point formulation of signal-to-noise ratio
(SNR) and a correction factor that establishes a relationship between the magnitude MR variance
and the variance of the underlying Gaussian noise in the quadrature channels. Hence the signal
intensity and the noise variance can be extracted simultaneously from a noisy magnitude MR
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signal. Although this method is computationally very efficient, it only works for homogeneous
region of interest (ROI) signals, and the fix point formula isn’t valid for all ranges of SNR and
hence isn’t always practical to deploy.
Several bodies of work on denoising have been proposed where the noise is assumed to be ad-
ditive white noise. BM3D42 is one such method that groups spatially similar 2-D image fragments
into 3-D groups and collaboratively filters these 3-D groups. Although many algorithms have
been proposed since BM3D, with a few claiming better performance than BM3D, recent research
shows that many that perform well on synthetic noise are outperformed by BM3D on images with
real noise.43 Therefore, BM3D arguably remains the state-of-the-art image denoising method for
white noise. BM4D44 is an extension of BM3D filter to volumetric data where mutually similar
3-D patches are stacked together in a 4-D array and jointly filtered in a transform domain. While
in BM3D the basic data patches are blocks of voxels, BM4D utilizes cubes of voxels, which are
stacked into a 4-D group. The key drawbacks of BM3D and BM4D filtering are two-fold: first,
they work poorly in scenarios when directly applied to non-additive noise corrupted images like in
the case of MR images. Second, although they make use of spatial similarity information within
an image, they ignore temporal correlation across multiple inter-dependent image sequences (e.g.
scans in DCE-MRI data).
In this paper we propose Temporo-Spatial Collaborative Filtering (TSCF), a novel denoising
technique that enhances sparse representation based on both temporal correlation and spatial sim-
ilarity of DCE-MRI time series. The sparsity is achieved by gathering similar voxels across the
entire time-series into clusters, hence preserving both the spatial and temporal similarity informa-
tion in them. These clusters are then collaboratively filtered for noise attenuation. This involves
three sub-steps: cluster transformation, noise attenuation and inverse transformation outputting a
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jointly filtered denoised set of clusters. By taking into account both temporal and spatial simi-
larity in the voxels grouped in a cluster, our denoising method achieves enhanced sparsity in the
transform domain and the noise can be attenuated by preserving a few high-valued transform co-
efficients. Finally, we unravel the clusters to return each voxel to their original positions in the
image. Because there exists a many-to-one mapping between clusters and voxel positions in the
image (i.e., each voxel can belong to multiple clusters), we perform a reduce operation on inten-
sity contributions from multiple clusters to get the final estimation of the denoised signal for each
voxel. We propose gather-noise attenuation and reduce (GNR) as a general denoising paradigm.
TSCF is an instantiation of GNR for DCE-MRI data.
In order to address the challenges associated with heteroskedasticity of DCE-MRI data and
to apply our proposed TSCF algorithm that works in the homoskedastic domain, we transform
the raw data using variance stabilization transformation (VST).35 After VST, the signal-dependent
noise in DCE-MRI can be treated as additive with unitary variance which ensures the sequential
noise estimation and denoising using TSCF. Finally the inverse-VST is applied to recover the
denoised signal, followed by PK parameter estimation to achieve optimal results.
To establish the efficacy of our proposed method and reproducibility of its results we designed
our experiments as per the guidelines of Quantitative Imaging Network (QIN)31,45 that the National
Cancer Institute has recently established for development and validation of quantitative imaging
tools. Experimental results of DCE-MRI data analysis, performed on a dataset from a digital
reference object (DRO)45 and human breast tumor dataset, demonstrate that our TSCF denoising
algorithm decreases the PK parameter normalized estimation error by 57% and improves the struc-
tural similarity of PK parameter estimation by 86% compared to baseline without denoising. Our
method beats the state-of-the-art denoising technique, BM4D, by taking into account both temporal
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correlation and spatial similarity information which was missing in previous DCE-MRI denoising
strategies. Besides accuracy improvement, our TSCF denoising is an order of magnitude faster
than BM4D. Finally, TSCF improves the univariate linear regression (ULR) c-statistic value for
early prediction of pathologic response up to 18%, and shows complete separation of pathologic
complete response (pCR) and non-pCR groups on breast cancer dataset.
To summarize our main contributions:
• We propose a 3-stage end-to-end denoising and PK parameter estimation pipeline for noise
corrupted DCE-MRI data.
• We proposed a general paradigm for signal restoration: gather-noise attenuate and reduce
(GNR). As an instantiation of GNR, we also propose Temporo-Spatial Collaborative Filter
(TSCF) denoising algorithm for noisy DCE-MRI, which achieves up to a 57% reduction in
normalized estimation error, and up to 86% improvement in the structural similarity of PK
parameter estimation than baseline method, and an order of magnitude speed up in execution
time than state-of-the-art denoising methods.
• We evaluate the proposed framework on both synthetic DRO phantom data and real human
breast data.
• We analyzed the early prediction of therapy response with and without denoising. TSCF
improves the ULR c-statistic value up to 18% for early prediction of pathologic response,
and is able to completely separate pCR and non-pCR groups.
The remainder of the paper is organized as follows: Section 2 discusses the proposed Temporo-
Spatial Collaborative Filtering (TSCF) technique for noise removal and pharamacokinectic param-
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Fig 2: Pipeline for Noisy DCE-MRI Data
eter estimation. Section 3 presents the experimental setup and results. Section 4 discusses the key
takeaways from the experimental results followed by conclusions and future work.
2 Proposed Methods
As shown in Figure 2, our proposed DCE-MRI parameter estimation pipeline consists of three
stages. In the first stage, we estimate the statistics of noise corrupted DCE-MRI data using a dual-
noise estimation technique assuming that the raw input data belongs to the Rician distribution.46
In the second stage, our novel temporo-spatial collaborative filtering technique accurately and
efficiently denoises the DCE-MRI raw data and restores the original signal by making use of both
temporal correlation and spatial similarity between pixels (or voxels; note that our algorithm works
for both 2-D and 3-D medical images. We use voxels in the following text for simplicity). Finally,
using the denoised data from the previous stage, Pharmacokinetic (PK) parameters are estimated
in a very computationally efficient manner by working in the concentration domain instead of
intensity domain. Next we discuss each of these pipeline stages in detail.
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2.1 Dual Noise Statistics Estimation
In the first stage of our pipeline, we estimate the noise statistics of the input data using a dual noise
estimation strategy, which is not only accurate but also computationally efficient by combining the
best of two existing methods. As shown in Appendix Equation (29), the magnitude of MR images
can be modeled by the Rice distribution,47 which has two parameters: unknown true signal (y),
and standard deviation of the additive noise (σg) that corrupts the real and imaginary part of the
input data.
Koay et al.34 proposed an analytically exact fixed point formulation of signal-to-noise ratio
(SNR), θ, and a correction factor ξ(θ) (Equation (32), appendix) that fundamentally relates the
variance of the magnitude MR signal (σ2m) and the variance of the underlying Gaussian noise in
the two quadrature channels (σ2g). Therefore, given the mean of the magnitude MR signal, µm,
and σm, using equation (32), one can determine the value of SNR in the image. We employ New-
ton’s method of root finding, as described in 34 to estimate the SNR, and thereby calculate y and
σg. Although, the above mentioned method is computationally very efficient for calculating the
SNR, it has two major limitations. First, the fixed point formula has a valid unique solution only
when µm
σm
≥
√
π
(4−π) = 1.91. Therefore, in scenarios when
µm
σm
is less than this threshold, the above
method will fail to estimate σg. Second, the first moment of noisy data is an ensemble average over
the noise fluctuations. Therefore this method works on calculating statistics of repeated measure-
ment of the same noiseless signal, or a ROI-based averaging when there are homogeneous signals
within the ROI.34 The limitations bring us to another noise-level estimation technique based on
variance-stabilization.
Foi et al.35 proposes variance stabilization transform (VST) that maps heteroskedastic MR data
8
(a) DCT of DRO v9 ground truth signals. (b) DCT of DRO v9 noisy signals.
Fig 3: Temporal correlation of DCE-MRI time series leads to energy concentration at low frequencies.
to a homoskedastic domain assuming that standard deviation of the noise σg is known. Further,
Foi35 employs a recursive approach to estimate the noise-level by iteratively updating σg so that
the standard deviation of the transformed data approaches some constant (e.g. 1). As each σg
update iteration involves a VST computation, this noise-level estimation strategy requires longer
execution time than Koay’s34 closed-form solution.
In our dual noise estimation stage, if there are homogeneous signals within the ROI, first we
calculate the ratio µm
σm
from the noise corrupted raw magnitude signal. If this is greater than a
given threshold (1.91), we estimate the SNR (θ ≡ y
σg
), using a fixed point formula (Equation (32),
appendix). Else we employ the computationally more intensive VST-based method to iteratively
estimate the standard deviation of the noise.
To summarize, in dual-noise estimation we make full use of the benefits of two existing meth-
ods. We first try the fixed point formula if the signal within the ROI is homogeneous (based on
prior or domain knowledge) and the magnitude SNR is in the valid range. Otherwise, we employ
the computationally more intensive VST-based iterative solution.
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Fig 4: TSCF Pipeline.
Fig 5: TSCF Gather.
2.2 Signal Restoration
The second stage of our pipeline is responsible for denoising the DCE-MRI input data using
the noise statistics estimated by the previous stage. Here we introduce a more general denois-
ing paradigm, gather-noise attenuation and reduce (GNR), using which a class of algorithms for
signal restoration can be implemented. GNR requires the algorithm designer to define three basic
primitives: 1) gather operation in which pixels (or voxels) are grouped together using an algorithm
specific similarity or affinity metric. 2) noise attenuate operation is a group operation that uses spe-
cial properties of these grouped pixels e.g. sparsity in the spectrum domain to collaboratively de-
10
noise them. Finally, 3) reduce operation is responsible for recovering true pixel intensities as some
algorithm specific function of the contributions from different denoised groups. The proposed
temporo-spatial collaborative filtering (TSCF) algorithm is an instantiation of the GNR paradigm,
specifically tailored to efficiently handle the task of denoising the DCE-MRI data sequence which
has both temporal and spatial information incorporated in them.
The key idea behind our proposed TSCF algorithm is to extract sparsity from the temporal cor-
relation and spatial similarity among the voxels in the DCE-MRI data. The signal restoration stage
can be broadly divided into three sub-steps: 1) A preprocessing step to apply VST35 to remove the
dependency of the noisy signal variance on the true underlying signal. In other words, it trans-
forms Rician noisy data to a signal with additive white noise. 2) Temporo-Spatial collaborative
filtering to remove the white noise and 3) finally a post-processing step to apply unbiased inverse
VST (IVST) on the denoised signal, to obtain the estimate of the signal of interest.
2.2.1 Temporal correlation in DCE-MRI time series
After applying VST, the noisy signal model for the input image of TSCF is
z(x, t) = y(x, t) + η(x, t), x ∈ X (1)
where z is the variance stabilized noisy image, y is the variance stabilized noiseless signal and x
is a 2-D or 3-D coordinate belonging to the signal domainX ⊂ Zd and d ∈ {2, 3}. t ∈ {0, 1, ..., N}
is the scan index, withN as the total number of scans, and η ∼ N (0, σv) is Gaussian white additive
noise with zero-mean and variance σv.
Based on Tofts model,2 from a spoilt gradient echo sequence, the intensity of DCE-MRI signal
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due to CA injection is modeled by Equation (2)
y(x, t) = y0(x)
(
1− e−TR/T1) sinθ
1− e−TR/T1cosθ (2)
y(x, t) = y0(x)
(
1− e−TR/T10e−TR∗r1∗Ct(x,t)) sinθ
1− e−TR/T10e−TR∗r1∗Ct(x,t)cosθ (3)
where y0(x) is the relaxed signal, TR is the repetition time, θ is the flip angle, Ct is the con-
centration of contrast agent in the tissue, T1 is longitudinal relaxation time of the tissue, T10 is
longitudinal relaxation time before injection of contrast agent, and r1 is the relaxivity.
Let
A = e−TR/T10 (4)
B = Acosθ (5)
D = −TR ∗ r1 (6)
so that
y(x, t)
y(x, t− 1) =
[
1− AeD∗Ct(x,t)] [1− BeD∗Ct(x,t−1)]
[1− BeD∗Ct(x,t)] [1− AeD∗Ct(x,t−1)] (7)
Equation (7) clearly shows that DCE-MRI time series of each voxel is temporally correlated.
Furthermore, Ct(x, t) and Ct(x, t− 1) are also correlated as shown in following equations.
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Ktrans′ (x) = K
trans (x)△t (8)
E(x) = e−Ktrans′ (x)/Ve(x) (9)
F (x, t) = Cp(t− 1) [E(x)− E(x)logE(x)− 1]
+Cp(t) [E(x)− logE(x)− 1] (10)
Ct(x, t) = Ct(x, t− 1) + Ktrans′ (x)
[logE(x)]2
F (x, t) (11)
where△t is the scan interval,Ktrans is the transfer constant which characterizes the diffusive trans-
port of low-molecular weight Gd chelates across the capillary endothelium,48 Ve is the fractional
volume of the extravascular extracellular space (EES).Ct(x, t) depends onCp(t), the concentration
of contrast agent in the blood plasma (i.e., the AIF), as well as PK parameters, such as Ktrans (x)
and Ve (x). Note that the population AIF, Cp, varies over time, whereas PK parameters Ktrans
and Ve depend on different tissue properties and hence vary spatially and anatomically, but do not
change over time. The correlation between Ct(x, t) and Ct(x, t − 1) is shown in Equation (11),
where piecewise linear representation 30 is used to model AIF in Tofts model.1
Since DCE-MRI time series is temporally correlated, transformations like the Discrete Cosine
Transform (DCT) concentrates its energy in lower frequencies (a few transformed coefficients), as
shown in Figure 3a. TSCF makes use of this sparsity in the spectral domain.
2.2.2 Temporo-Spatial Collaborative Filtering (TSCF)
The proposed temporo-spatial filtering is a type of transform-domain denoising technique where
the true signal intensity can be approximated by a linear combination of few basis elements. This
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involves three basic steps: 1) Gather, 2) Noise attenuation with collaborative filtering and 3) Re-
duce. The overall algorithm for TSCF is summarized in Algorithm 1.
Algorithm 1 Temporal Spatial Collaborative Filtering (TSCF)
Input: A variance stabilized noisy image Z, and the image’s signal domain X ⊂ Zd, where
d ∈ {2, 3}.
Output: A denoised image Yˆ, which is an estimation of the noiseless imageY.
1: while stopping criterion not met do
2: Transform each voxel’s DCE-MRI time series (temporal transform), z(x, :), into spectral
domain, denoted as Tt (z(x, :)).
3: for each reference voxel xr ∈ X do
4: Gather:
5: Calculate spatial distance with respect to the reference voxel, xr, with Equation (12).
6: Calculate temporal similarity with respect to the reference voxel in spectral domain
with Equation (13).
7: Form a cluster, P zxr , for the reference voxel xr based on Equation (14). C
z
xr is the
corresponding cluster data in spectral domain, as shown in Equation (16).
8: Noise Attenuation with Collaborative Filtering:
9: Apply spatial transform on each cluster to leverage spatial similarity across different
voxels within a cluster, denoted as Ts
(
Czxr
)
.
10: Perform empirical Wiener filtering on the temporally and spatially transformed 2-D
matrix in spectral domain, with Equation (18) to Equation (20)
11: Transform filtered signal back into original signal domain with Equation (21). An
estimation on the noiseless signal within this cluster is represented by Gˆzxr .
12: end for
13: Reduce:
14: for each voxel xi ∈ X do
15: Find the set of clusters this voxel contributed to, Jxi , by Equation (22).
16: Compute the final estimation for this voxel, yˆ(xi, :), with estimations from different
clusters by Equation (23)
17: end for
18: end while
The following subsections present the sub-steps of our proposed TSCF algorithm in detail.
a) Gather: This step involves finding similar voxels in the 2-D (or 3-D) signal domain and
combining them across the entire time-series of DCE-MRI input data into collections that we call
clusters. Hence the gather operation exploits potential similarity (correlation, affinity, etc) in both
temporal and spatial domain of DCE-MRI data. The opportunity for such voxel similarity across
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the image sequence arises because of mainly three reasons: 1) DCE-MRI has a higher temporal
resolution compared to the diffusion rate of the contrast agent (CA). Hence, the per-voxel intensity
change due to CA diffusion in the entire DCE-MRI image sequence renders the voxels in the same
location across different time points correlated to each other, as shown in Equation (7) and Equation
(11); 2) Due to anatomical spatial similarity, the pre-contrast voxel intensities of voxels with same
or similar tissue types are very close to each other; 3) Finally the anatomical similarity also leads
to similarity in pharmacokinetic tissue properties that in turn result in similar CA concentration in
the tissue.
The spatial distance between two voxels xi and xj are measured by squared Euclidean distance
of their coordinates as shown in Equation (12). Let z(x, :) denote the noisy DCE-MRI time series
of the voxel at the coordinate x ∈ X. As shown in Figure 4, in the Gather step, the transformation
is first applied to each time series z(x, :). Then the similarity between any pair of voxels, s(xi, xj),
is measured by the squared Euclidean distance between transformed time series in spectral domain
as shown in Equation (13), where Tt (·) is the temporal transformation on the time series of a
voxel.
d(xi, xj) = ∥xi − xj∥22 (12)
s(xi, xj) = ∥Tt (z(xi, :))−Tt (z(xj, :)) ∥22 (13)
TSCF loops over all voxels, giving each voxel a chance to become the reference voxel. For
each reference voxel xr, its similarity to any other voxel is sorted, and a cluster of similar voxels
are formed for this reference voxel based on both the similarity metric and the spatial distance.
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As shown in Equation (14), we define the cluster formed using the reference voxel xr as P zxr .
Since each element in this cluster is already a vector, we organize the voxels in this cluster row
by row. Therefore, no matter whether the original noisy signal is in 2-D or 3-D signal space, the
cluster of each reference voxel forms a 2-D matrix Gzxr in the original signal domain as shown in
Equation (15), and forms a 2-D matrix Czxr in spectral domain as shown in Equation (16).
P zxr = {xi | xi ∈ X ∧ s(xr, xi) ! ζsim ∧ d(xr, xi) ! τdist} (14)
Gzxr = z
(
P zxr , :
)
(15)
Czxr = Tt
(
z
(
P zxr , :
))
(16)
The significance of the gather operation is to enable collaborative filtering of voxels in each
cluster by exploiting the enhanced sparsity in the spectral domain introduced by intelligently in-
corporating voxel similarity information across both the temporal and spatial domain.
b) Noise Attenuation with Collaborative Filtering: Given a cluster of similar voxels, col-
laborative filtering of the cluster produces denoised estimates of the voxels. This has 3 sub-steps
1) Cluster transformation, 2) Noise attenuation with empirical Wiener filtering49 and 3) Inverse
cluster transformation.
1) Cluster transformation: For each cluster formed in the Gather step, we firstly apply spatial
transformation over voxels in the cluster(Ts (·)), as shown in Equation (17). This operation extracts
the spatial similarity and gets Szxr , which is a 2-D matrix in spectral domain. Because of spatial
similarity, Szxr is sparse.
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2) Empirical Wiener filtering: We use empirical Wiener filtering to attenuate the noise.
Szxr = Ts
(
Czxr
)
(17)
Hzxr (u, v) =
⎧⎪⎪⎪⎨⎪⎪⎪⎩
Szxr(u, v) if
∣∣Szxr(u, v)∣∣ " τ
0 otherwise.
(18)
W zxr (u, :) =
∥Hzxr (u, :) ∥22
∥Hzxr∥22
(19)
U zxr = W
z
xrS
z
xr (20)
where u and v are the transform frequencies in 2-D spectral domain. τ is the threshold for atten-
uating noise and calculating weights of Wiener filter. Although the weightsW zxr are calculated on
thresholded 2-D spectrum signalHzxr , the Wiener filtering itself is applied to the original spectrum
signal Szxr as shown in Equation (20).
3) Inverse cluster transformation: As shown in Equation (21), after Wiener filtering, the 2-
D spectrum data is transformed first back into spatial domain (T −1s (·)), and then into the time
domain(T −1t (·)). After these two steps of inverse transformation, we get Gˆzxr , the denoised esti-
mation of Gzxr , in the original signal domain, as shown in Equation (21).
Gˆzxr = T
−1
t
(
T −1s
(
U zxr
))
(21)
c) Reduce: In the Gather and Noise Attenuation steps, each voxel can belong to several differ-
ent clusters. As shown in 5, the light green voxels belong to both Cluster A with reference voxel A,
and Cluster B with reference voxel B, because of their similarity to voxel A and voxel B in spectral
domain. In the Reduce step, the final estimation of the DCE-MRI time series is the average of
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(a) Concentration based PK estimation (b) Intensity based PK estimation
Fig 6: Different types of PK estimation pipeline
estimations from each cluster it contributed to, as shown in Equation (23).
Jxi = {xj | xi ∈ P zxj ∧ xi ∈ X ∧ xj ∈ X} (22)
yˆ(xi, :) =
∑
xj∈Jxi
(
Gˆzxj(xi, :)
)
|Jxi |
(23)
where Jxi defines a set of reference voxels which xi clustered with, and |Jxi | is the cardinality
of set Jxi .
The sequence of Gather, Noise Attenuation, and Reduce forms one iteration of TSCF. This
sequence can be configured to run iteratively until the standard deviation of denoised data no
longer changes statistically.
The overall signal restoration stage can be summarized in Equation (24).
yˆ = IVST (TSCF (VST (z, σg) , σv) , σg) (24)
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2.3 Pharmacokinetic (PK) Parameter Estimation
This stage is responsible for accurate and efficient estimation of PK parameters from denoised
DCE-MRI data from the signal restoration stage.
2.3.1 Theory
The change in DCE-MRI intensity due to CA injection is modeled in Equation (2). Given the Gd
concentration as a function of time, PK analysis models how the CA distributes in the body, and
its dependency on characteristics of the tumor/tissue biology. One well-accepted PK model is the
Tofts model (TM),1 which assumes the diffusible tracer diffuses into the tissue’s extracellular space
at a rate that is proportional to the instantaneous concentration difference between the plasma and
the tissue distribution space, as shown in Equation (25):
Ct(t) = K
trans
∫ t
0
Cp(τ)exp(
−Ktrans(t− τ)
ve
)dτ (25)
where Ct(t) is the concentration of CA in the tissue at time t, and Cp is the blood plasma
concentration of CA.
The objective of PK analysis is to estimate important PK parameters, such as Ktrans and Ve,
from the DCE-MRI tissue intensity signal yˆ.
2.3.2 PK Estimation Pipeline
As shown in Figure 6a, the PK estimation pipeline involves three sub-steps : 1) Bolus Arrival Time
(BAT) estimation, 2) blood/tissue concentration calculation and 3) PK parameter estimation. As
the output of one sub-step is used in the next, the accuracy in each of these sub-steps is crucial for
the overall precision and reproducibility of the PK parameter estimation.
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a) BAT estimation: Previous studies demonstrate that alignment of the BAT of the AIF and
tissue residual function (TRF) can have a large effect on the accuracy of estimation of PK param-
eters .50–52 As shown in Figure 1a, with the injection of the CA, the change in its concentration in
blood/tissue with time is reflected in the DCE-MRI time series. The objective of BAT estimation
is to identify the rising edge in this time varying CA concentration to align the BAT of the AIF
and TRF. The fundamental challenge in accurate BAT estimation is that when an image scan is
corrupted with noise, it becomes more difficult to identify this rising edge (as shown in Figure 1b)
when compared to the case of noiseless signal (as shown in Figure 1a). Hence image denoising is
an effective way to improve the accuracy of the BAT estimation.
We used an in-house implementation of the gradient based method52 to estimate BAT. The only
difference is that we perform BAT estimation on intensity values rather than concentration values.
This is because the computation of concentration values from intensity values requires correct pre-
contrast values, as shown in Equation (26). But the clear separation of pre- and post-contrast data
is unknown before BAT estimation. Conversion from intensity to concentration is not guaranteed
to be accurate before BAT estimation, so we chose to estimate BAT directly from intensity values,
without conversion. Precise BAT estimation is fundamental in accurately separating pre- and post-
contrast AIF and tissue intensity, which in turn is important for accurate model fitting to recover
the PK parameters.
b) Compute Tissue/Blood Concentration from Tissue/Blood Intensity:
Based on Equations (2),(4),(5), and (6), we can compute tissue concentration from tissue in-
tensity as shown in Equations (26) to (28), where y(x, 0) is the pre-contrast tissue intensity.
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y(x, t)
y(x, 0)
=
[1− AeD∗Ct(x,t)](1− B)
[1− BeD∗Ct(x,t)](1− A) (26)
γ(x, t) =
y(x, t)(1− A)
y(x, 0)(1− B) (27)
Ct(x, t) =
1
D
log
[
1− γ(x, t)
A− Bγ(x, t)
]
(28)
If available AIF information is in blood intensity format, we can calculate blood concentra-
tion Cb(t) from blood intensity by using T1 of blood in Equation (28), and then compute plasma
concentration Cp(t) with hematocrit Hct and Cb(t).
c) PK Parameter Estimation: This stage poses the problem of PK parameter estimation as
an optimization problem to find the best curve fit of the model using the concentration data of
both blood (AIF) and tissue. In this paper, we use constrained nonlinear optimization algorithm
L-BFGS53 to estimateKtrans and Ve.
As shown in figure 6a, we first randomly initialize the tissue parameter maps (Ktrans and Ve)
and then using Tofts model1 and piecewise linear representation of AIF,30 calculate the estimated
tissue concentration for each time point with Equation (8) to Equation (11). We compare this tissue
concentration estimation with true concentration information (i.e., calculate the cost function), and
generate newKtrans and Ve estimates based on the gradient of the cost function. We continue until
the concentration values calculated from estimated Ktrans and Ve are similar to true data within a
user-defined threshold.
There are a couple of steps in the PK parameter estimation that require particular attention for
accuracy and computational efficiency. First, the concentration estimation using the Tofts model
(Equation (25)) involves an integration step to be computed for each time point in the DCE-MRI
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Fig 7: DRO v9 Parameter Ground Truth.
sequence and to be repeated for every iteration of the optimization loop. The piecewise linear
representation of AIF and recursive calculation of concentration values proposed by Horsfield et
al.30 is much faster than directly performing numerical integration on Cp.
Second, when we use concentration based PK estimation, as shown in Figure 6a, before the
main parameter estimation loop, we need to convert the tissue intensity to tissue concentration
values once using Tofts model (Equation (26) to (28)). An alternative method is to use intensity
based PK estimation, as shown in Figure 6b, where we can save the calculation of concentration
from intensity values once before the main PK estimation loop. However, within the main PK
estimation iteration, whenever a new Ktrans and new Ve are estimated, we need to compute tissue
intensity from tissue concentration, as highlighted in the orange box. Since this calculation happens
in each iteration of the main PK estimation loop, intensity based PK estimation takes longer than
concentration based PK estimation. Therefore, we use concentration based PK estimation in our
framework.
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3 Results
3.1 Data
3.1.1 Simulated Digital reference object (DRO) DCE-MRI
DRO DCE-MRI phantoms with known PK parameter values provide an effective way to validate
and compare different DCE-MRI data analyses. The Quantitative Imaging Biomarker Alliance
(QIBA) and Duke University have generated a series of DRO DCE-MRI phantoms.45 We use the
DCE-MRI DRO version 9 for the denoising study in this paper.
In the dataset DCE-MRI DRO version 9, noisy data was modeled using Equation (29)
(see Appendix). The DRO phantom we use, QIBA_v9_Tofts_S0_500_6s_0s_sigma_5,
has a sampling interval of 6 seconds, timing offset of 0 seconds, and standard deviation of 5 for the
noise. The trueKtrans and Ve 2D maps of DCE-MRI DRO version_9 are illustrated in Figure
7. Six Ktrans values {0.01, 0.02, 0.05, 0.1, 0.2, 0.35} and five Ve values {0.01, 0.05, 0.1, 0.2, 0.5}
vary along the y− and x−axis respectively. There are 30 combinations of Ktrans and Ve in total;
each combination occupies 10 × 10 pixels. The AIF ROI is in the bottom 50 × 10 pixels. The
DRO simulated 360 seconds of imaging, with injection of CA occurring at 60 seconds. The MR
parameters used in the generation of the DRO are: flip angle 30◦, repetition time 5 ms, a pre-
contrast T1 (T10) of 1000 ms in tissue and 1440 ms in blood, a blood hematocrit of 45%, and the
relaxivity of the gadolinium CA at 1.5 T was assumed to be 0.0045 mmol−1ms−1.
3.1.2 Breast cancer DCE-MRI data
With consent from patients and approval from the local Institutional Review Board (IRB), Oregon
Health and Science University (OHSU) as an individual Quantitative Imaging Network (QIN) cen-
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ter acquired the TCIA QIN Breast DCE-MRI dataset from ten patients with locally advanced
breast cancer who underwent preoperative neoadjuvant chemotherapy (NACT).31,54 For each pa-
tient, four DCE-MRI sessions were acquired during the treatment course: pre-NACT (visit 1, V1),
after the first cycle of NACT (visit 2, V2), at a NACT midpoint (usually after the third NACT
cycle; visit 3), and after the completion of NACT (visit 4). After all four DCE-MRI sessions,
three patients were identified by doctors as with pathologic complete response (pCR), the rest
seven patients are non-pCRs (which includes both pathologic nonresponse and pathologic partial
response).
The DCE-MRI images were acquired using a Siemens 3T system with a body coil transmitter
and a four-channel bilateral phased array breast coil receiver. According to Huang et al.,54 DCE-
MRI acquisition parameters included 10◦ flip angle, 2.9/6.2 ms echo time/repetition time (TE/TR),
a parallel imaging acceleration factor of two, 30 to 34 cm field of view (FOV), 320 × 320 in-
plane matrix size, and 1.4 mm slice thickness. The total acquisition time was ∼ 10 minutes for
32 to 34 image volume sets of 112 to 120 slices, each with 18 to 20 seconds temporal resolution.
The time of injection of CA (HP-DO3A) [ProHance] IV (0.1 mmol/kg at 2 ml/s) was set to start
following acquisition of two baseline image volumes using a programmable power injector and
followed by a 20 ml saline flush. A population-averaged AIF was provided, and it was generated
by averaging individually measured AIF from an axillary artery in a previous breast DCE-MRI
study.55 The population AIF has a 10x higher resolution compared to the DCE-MRI data. The
TCIA QIN Breast DCE-MRI dataset are available in the TCIA56 QIN breast DCE-MRI col-
lection. In this paper, we use publicly available TCIA QIN Breast DCE-MRI V1 and V2 data
to perform early clinical prediction using therapy response.
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3.2 Experimental Method and Evaluation
3.2.1 Signal Restoration in DRO v9 Rician noisy data
For DCE-MRI DRO version_9 data, both data and AIF intensities are corrupted with Rician
noise. For each scan, we have 50 × 10 noise corrupted samples of the same AIF intensity value.
Using our PK parameter estimation framework, discussed in detail in previous sections, we esti-
mate the “true” signal which is briefly discussed as follows. First we estimate the noise statistics of
the pre-contrast AIF intensity values e.g., white noise sigma (σˆg) and the AIF_X0 (noiseless pre-
contrast AIF) using dual-noise estimation. For post-contrast noisy AIF data, using the estimated
σˆg, and the observed mean and standard deviation of the post-contrast AIF intensity, we estimate
the true value of the AIF data. We then estimate the data_X0 (noiseless pre-contrast image data)
based on dual-noise estimation from pre-contrast data intensity values. Finally, using our novel
TSCF algorithm, we denoise and estimate noiseless signal for post-contrast image data.
• PK estimation results on DRO v9 data
To evaluate the efficacy of the proposed TSCF algorithm on signal restoration and hence PK param-
eter estimation, we compare its performance with the state-of-the-art denoising method, BM4D,
commonly used Gaussian spatial smoothing, and the baseline method of parameter estimation
without denoising. In the evaluation process we the estimated Ktrans and Ve values from denois-
ing and data fitting from different algorithms were compared with the ground truth Ktrans and Ve
values that were used to construct the DRO data. We used two performance metrics, namely nor-
malized root mean square error (NRMSE) and mean structural similarity (MMSIM) index which
are briefly described below.
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(a) DRO v9 baseline results. (b) DRO v9 spatial smoothing results.
(c) DRO v9 BM4D results. (d) DRO v9 TSCF results.
Fig 8: DRO v9 results
(a) DRO v9 NRMSE results. (b) DRO v9 MSSIM results.
Fig 9: DRO v9 NRMSE and MSSIM forKtrans and Ve.
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Suppose there are n number of voxels, the true PK value is x, and the estimated PK value is
xˆ, the NRMSE is defined as
√∑n
i=1(xˆi−xi)2
n
xmax − xmin . The expected ground truth 2D K
trans and Ve map is
shown in Figure 7 and the estimated Ktrans and Ve maps obtained using different denoising algo-
rithms and parameter estimation methods are shown in Figure 8. By visually inspecting Figures 8,
we can very easily observe that parameter estimation using our TSCF algorithm (Figure 8d) is
much more closer to the ground truth PK parameter in comparison with all other methods. The
BM4D method (Figure 8c) visually comes close to our method but not as accurate as TSCF which
we will quantify shortly and the baseline method without any denoising technique performs the
worst of all(Figure 8a). One of the most commonly used denoising techniques popular for it’s
simplicity, Gaussian spatial smoothing performs in between (Figure 8b).
In order to quantify the performance we also plot the corresponding NRMSE and MMSIM
numbers for each of these methods in Figure 9. We can observe from Figure 9a that the lowest
NRMSE (hence the highest accuracy in PK parameter estimation) on the raw DRO v9 data is
achieved by our TSCF methods with NRMSE of 0.13 for bothKtrans (in min−1) and Ve which is a
substantial improvement of 28% over the state-of-the-art BM4D filtering which has a NRMSE of
0.18 for both Ktrans and Ve.
Several factors contributed towards the better performance of our TSCF algorithm compared
to BM4D on DCE-MRI data. First, TSCF makes full use of the information available in the entire
dataset by incorporating both spatial and temporal information from the DCE-MRI time series,
whereas in BM4D, 3-D images are chopped into small cubes, inside a similarity group, only a small
fraction of every voxel’s time series is analyzed. Hence, BM4D only utilizes local information,
whereas TSCF takes advantage of complete time series information. Secondly, in TSCF, voxel
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similarity is measured after performing per-voxel time series transformation. This means voxel
similarity is measured in spectral domain (Figure 3b, majority energy locates at low frequency
components), whereas in BM4D cube similarity is measured in the raw signal domain, which
can result in significant inaccuracy in voxel clustering. As shown in Figure 1b, noise corrupted
DCE-MRI can completely lose its original CA response pattern and hence it becomes extremely
difficult to distinguish voxels with different PK values in the noisy raw signal domain. This makes
similarity measure in noisy raw signal domain less accurate. Figure 8a shows that estimating PK
parameters by directly applying Tofts model results in the least accurate parameter estimation with
the highest NRMSE (0.30 min−1 onKtrans and 0.29 on Ve, Figure 9a) among all the methods. This
is because the true signal is corrupted with noise and is used in model fitting without removing the
the noise from the signal. Gaussian spatial smoothing (Figure 8b) with full width at half maximum
(FWHM) of 1.5 improved the NRMSE compared to direct estimation to 0.23 min−1 and 0.19
for Ktrans and Ve (Figure 9a), respectively but falls short compared to more advanced TSCF and
BM4D denoising methods. Our TCSF method of PK parameter estimation achieves up to 57%
improvement in estimation accuracy.
Besides NRMSE, we also measured MSSIM index57,58 between estimated and the ground truth
PK maps. MSSIM is a perception-based model that considers image degradation as a function
of human perceived change in structural information. The key idea is that spatially close voxels
have strong inter-dependencies and these dependencies carry important structural information in
an image. The higher the MSSIM index value on the estimated PK map, the closer the result
is to the ground truth. The advantage of the MSSIM index is that it relates to the human visual
system better than mean squared error based methods, and it works in both 2-D images57 and 3-D
images.58 As shown in Figure 9b, estimating PK values on raw DRO v9 data attains the lowest
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Table 1: Parameter settings of TSCF and BM4D
Parameter Symbol
Image size A× B × T
Number voxel V , note V = A× B
Number time points (scans) T
BM4D cube size L
BM4D group size M
BM4D step size Nstep
BM4D search-cube size NS
BM4D total num of cubes Nc =
⌈
A−L
Nstep
⌉⌈
B−L
Nstep
⌉⌈
T−L
Nstep
⌉
BM4D num of cubes per search-cube Nsc =
⌈
NS−L
Nstep
⌉3
TSCF cluster size M
TSCF reduce size N
TSCF number iteration K
Table 2: Runtime of TSCF and BM4D
Image Size BM4D time (s) TSCF time (s) Speedup
30× 30× 61 34.5 1.4 23.9
40× 40× 61 73.0 3.1 23.8
50× 50× 61 145.1 5.3 27.6
50× 60× 61 187.8 6.5 28.9
MSSIM index value (0.50 on Ktrans map and 0.44 on Ve map) amongst all the methods. Spatial
smoothing and BM4D further improves this index to up to 0.89 and 0.88 respectively for Ktrans
and Ve respectively. Finally, our TSCF method achieves the highest MSSIM index value with
25.6% and 5% improvement in MSSIM index compared to Spatial smoothing and BM4D, and an
over all improvement of 86% over the baseline method. This further reinforces that our proposed
TSCF method substantially performs, both quantitatively and qualitatively, better than existing
noise canceling and parameter estimation methods on DRO v9 data.
• Computational Performance Analysis
To evaluate execution time, we used in house implementation of BM4D and TSCF, both in
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Python for fair comparison. The experiment is run on a compute node containing two 18-core
Intel R⃝ Xeon R⃝1 E5-2699 v3 processors each running at 2.3 GHz and equipped with 256 GB DDR4
memory. We used multi-processing to speedup BM4D using 36 processes. The parameters of
BM4D and TSCF are defined in Table 1. For BM4D parameters listed in Table 1, we use the
values recommended in the BM4D paper.44 Although both BM4D and TSCF have time complex-
ity linear with respect to the image size (O(V T )), the constant factors in the complexity function
makes the BM4D algorithms significantly more computationally expensive compared to the pro-
posed TSCF algorithm. The sliding window based search method for group formation and the
transform in the 4-th dimension renders BM4D (V T (L3M logL + L3M logM)) less computa-
tionally efficient than TSCF (V T (log T +M logM)). The execution time of TSCF and BM4D
on different sizes of images are presented in Table 2. For each image size, the reported time is the
mean runtime of three executions. Overall, TSCF is an order of magnitude faster than BM4D, and
the amount of speed up is a function of the image size and other configuration parameters. For
DCE-MRI DRO version_9 data with effective tissue intensity in 50 × 60 × 61 size, TSCF is
28.9X faster than BM4D.
3.2.2 Signal Restoration in OHSU Breast Cancer Data
In TCIA QIN Breast DCE-MRI data, the contrast agent (CA) was injected after acquisition
of two baseline image volumes. However the Bolus Arrival Time (BAT), which is very crucial
in accurately aligning AIF and scan data to correctly apply Tofts model, is unknown and varies
with different acquisition sessions. Therefore, as discussed in previous sections, data fitting for PK
parameter estimation is preceded by BAT estimation. We use a gradient-based method to estimate
1Intel and Xeon are trademarks of Intel Corporation or its subsidiaries in the U.S. and/or other countries.
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BAT for each voxel within a Tumor ROI (TROI), and use the mean BAT across ROI voxels to
align tissue and AIF data. Since AIF data has 10x higher resolution compared to tissue data, after
calculating BAT on tissue data, we shift AIF data based on 10x of tissue BAT, and then down
sample AIF by 10x for final PK estimation.
• BAT Estimation Results
When the CA is injected, the tissue concentration and intensity changes due to diffusion of CA and
hence we can observe (as shown in 1a) that the CA concentration curve rises, reaches a peak and
finally falls with time. As noise can corrupt the CA concentration rising edge of different voxels
differently (as shown in Figure 1b), we expect to see higher variance on BAT estimation across
voxels within a TROI on noisy data than on denoised data. Hence the variance in the BAT can be
used as a metric to estimate the effectiveness of our noise canceling algorithm with a low variance
signifying a more accurate BAT estimation that helps in better AIF and data alignment for more
accurate model fitting later in the pipeline. As shown in Figure 10, for both visit 1 and visit 2
data, after removing noise with TSCF, the variance of estimated BAT on valid voxels52 in Tumor
ROIs (TROIs) is reduced by 26% and 32%, respectively when compared to without denoising.
In other words, TSCF improved the consistency of BAT estimation in TROIs. The key reason
behind the variance improvement in visit 2 greater than visit 1 is that the mean of estimated noise
standard deviation across subjects, σˆg, is larger in visit 2 when compared to visit 1. Hence these
results confirm that with our proposed method TSCF, the variance of BAT estimation across voxels
within TROIs is substantially reduced in both visit 1 and visit 2 than BAT estimation without noise
removal.
• PK Parameter Estimation Results
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(a) Standard Deviation of BAT on Visit 1. (b) Standard Deviation of BAT on Visit 2.
Fig 10: Standard deviation of bolus arrival time (BAT) on raw input data and denoised data using
TSCF for patient visit 1 and 2.
For the TCIA QIN Breast DCE-MRI dataset, Huang et al.31 reported the PK estimation re-
sults from twelve software tools31 in their multicenter variations study of DCE-MRI for estimating
breast cancer response. Six out of twelve software tools used Tofts model (TM) based PK estima-
tion which is also the model of choice for our proposed PK estimation framework. Figure 11 shows
box plot for the estimatedKtrans, Ve and kep values for V1 and V2 and the corresponding percent-
age change between V2 and V1 are shown in Figure 12. Although there are no ground truth on
Ktrans, Ve and kep values for this real data, our results are very much in the same range of Ktrans,
Ve and kep values as obtained from different TM based PK estimations in Huang et al.31 Similar to
TM based results reported by Huang et al.,31 from visit V1 to V2, the mean tumor Ktrans and kep
value decreases, while the mean tumor Ve value increases in the TCIA QIN Breast DCE-MRI
dataset. With TSCF, in most cases (Ktrans V1, Ktrans V2, Ve V2 and kep V2), the variance in the
estimated pharmacokinetic parameter values decreases significantly, showcasing the effectiveness
of TCSF on real data. We will next explore the advantage of using our framework on end-to-end
prediction of therapeutic response.
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(a)Ktrans estimation (b) Ve estimation
(c) kep estimation
Fig 11: PK estimation results on TCIA QIN Breast DCE-MRI data
(a) PK parameters estimated from raw data. (b) PK parameters estimated from TSCF denoised
data.
Fig 12: Percentage change in mean tumorKtrans, Ve and kep between visit 1 and 2 with raw data
and with our TSCF algorithm. The central bar represents the median values.
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Table 3: DCE-MRI Parameter univariate logistic regression(ULR) c-Statistic Value for Early
Prediction of Pathologic Response
Parameter Algorithm V1 V2 %Change(V21)
Ktrans BAT TM 0.524 1.0 0.952
TSCF BAT TM 0.619 1.0 1.0
Ve BAT TM 0.619 0.857 0.714
TSCF BAT TM 0.619 0.905 0.714
kep BAT TM 0.524 1.0 0.952
TSCF BAT TM 0.619 1.0 1.0
• Prediction of therapeutic response
Early prediction of therapeutic response in cancer patients can be tremendously useful and possibly
life saving. It helps doctors to better plan personalized treatment for different patients, and it
helps patients to avoid unnecessary chemotherapy. Similar to the multicenter DCE-MRI analysis
challenge,31 our objective is also to perform early prediction of pCR using only the first two DCE-
MRI sessions.
The univariate logistic regression (ULR) c−statistic values for early discrimination of pCR
and non-pCR are listed in Table 3. For each PK parameter, Ktrans, Ve and kep, we list c−statistics
based on V1 only, V2 only, as well as its percentage change (V21). BAT TM means BAT estimation
and Tofts model based PK estimation are performed on raw data without denoise. TSCF BAT TM
means we first denoise with TSCF, then perform BAT estimation and Tofts model based PK estima-
tion. Our results confirm the observations from31 that 1) none of the PK parameters at pre-NACT
(V1) provide good (0.8 ≤ c < 0.9) to excellent (0.9 ≤ c ≤ 1.0) discrimination; 2) V2 and V21
provide much better discrimination than V1, and they are able to provide good to excellent dis-
crimination; 3) Ktrans and kep provide much better discrimination than Ve. More importantly, our
results show that for all PK parameters and all cases, V1, V2 and V21, the c−statistic values from
TSCF is either same or higher than the c−statistic values from baseline case without TSCF.
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Figure 13 and Figure 14 respectively presents the scatter plots of the percentage changes (V21)
on mean tumor Ktrans and kep, and that for each patient. From Figure 13b, we can observe that
by directly using raw data without any noise removal to separate pCRs from non-pCRs show some
overlap in the data point and hence isn’t clearly separable. On the other hand with TSCF, as shown
in Figure 13b, Figure 14c, and Figure 14d, we can completely separate pCRs from non-pCRs using
V21 data with a linear decision boundary. To quantify this, from Table 3 we can observe that ULR
c−statistic for percentage change in both Ktrans and kep values achieve ideal value of 1 and an
improvement of up to 18% over the prediction using noise corrupted real data.
Figure 15 shows the color tumorKtrans maps of non-pCRs (Figure 15a) and pCRs (Figure 15b)
at visit V1 and V2 using our proposed TSCF denoising method. The tumor Ktrans map of each
subject is generated for all tumor ROIs on the entire DCE-MRI time series and all Ktrans maps
are overlaid on pre-contrast DCE-MRI images. For each subject at each visit, the Ktrans map
is shown on the slice through the center of the tumor. As shown in the color maps, the Ktrans
values for pCRs in the tumor ROI clearly gets reduced between visit V1 to V2 (for example, red to
blue), while for non-pCRs very small variation (both positive and negative) in their Ktrans values
is observed. These observations are consistent with the expected result that as Ktrans is usually
higher in tumor tissue than in normal tissue, and the pCRs completely respond to the therapy, we
observe a fall in the Ktrans values in the tumor ROI between visit V1 and V2. On the other hand,
the non-responder non-pCRs have small to no change in their Ktrans values. The color kep maps,
which have been omitted due to space limitation, also show very similar pattern for both the pCRs
and non-pCRs.
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(a) without TSCF (b) with TSCF
Fig 13: Scatter plots of percentage change in tumorKtrans and kep between visit 1 and 2 for early
prediction of pathologic response. Three pCRs are shown as blue triangles and seven non-pCRs
are shown as red circle.
(a) without TSCF (b) without TSCF
(c) with TSCF (d) with TSCF
Fig 14: Scatter plots of percentage change in tumorKtrans and kep between visit 1 and 2 for early
prediction of pathologic response. Three pCRs are shown as blue triangles and seven non-pCRs
are shown as red circle
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(a) non-pCR
(b) pCR
Fig 15: V1 and V2 single slice tumorKtrans parametric map. The color Ktrans maps are overlaid
on pre-contrast DCE images.
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4 Discussion
TSCF is designed specially for DCE-MRI data. BM3D/BM4D are general method with no specific
image type in mind they were designed. Although both TSCF and BM4D utilize spatial similarity,
TSCF takes advantage of unique temporal property of DCE-MRI. As shown in Figure 8, Figure 9
and Table 2, TSCF is more accurate and faster than other denoising methods such as BM4D. In
DCE-MRI, for each voxel, we capture a series of scans before and after CA injection. The energy
of the noiseless version of this time series is primarily linked to low frequency components, as
shown in Figure 3a. When the DCE-MRI signal is corrupted with noise, energy also shows up at
higher frequencies. As shown in Figure 3, the value of the DC component also changes because of
noise. For voxels with similar PK parameter values, lower frequency components are quite similar.
Even when they are corrupted with noise, the low frequency components still contain most of
the energy. Since the noise of different voxels are independent, the noise triggered high frequency
components can show up as different patterns. This property inspired us to do collaborative filtering
to attenuate noise on the time series of a group of similar voxels. We consider the problem in both
the spatial/voxel and temporal domain. In Particular, we use the transformation of each voxel’s
time series as the signature of the voxel. In BM4D, noisy observations are directly tested for
similarity, and this similarity is used for grouping cubes. A time series of a voxel is analyzed
portion by portion in BM4D method, without using the full characteristic of each time series.
Our PK estimation results are consistent with recent observations59–61 that pharmacokinetic
biomarkers have earlier response time than more routine standard of care metrics, such as tumor
size changes. As shown in the color tumor Ktrans maps (Figure 15b), two out of three pCRs have
the ROI size increased from V1 to V2 (e.g. for patient BC15 the number of voxels in tumor ROI
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increased from 3410 to 10577), which might have indicated a radiologist of a non-response to the
therapy if only routine standard metrics like tumor ROI size is used for evaluation. Using our TSCF
based pharmacokinetic parameter estimation, the percentage change of Ktrans values from V1 to
V2 correctly predicted them as pCRs and hence successfully carrying out a correct early therapy
response prediction in the subjects.
Another key thing to note is that in this paper we have proposed a more general denoising
paradigm gather-noise attenuate-reduce (GNR) and our denoising algorithm TSCF, is an instan-
tiation of the GNR paradigm, which is specifically tailored for DCE-MRI sequences. In GNR
we have introduced three primitives: 1) gather, responsible for grouping pixels(or voxels) using
some similarity metric that helps in advanced noise filtering by taking advantage of the grouping
attributes, 2) noise attenuate, uses the special attributes of these grouped pixels (e.g. sparsity in
spectrum domain) to collaboratively denoise them and finally 3) reduce operation to recover the
true pixel intensities as a function of the contributions from different denoised groups. Using these
three primitives one can implement domain specific denoising algorithms targeted to different ap-
plications and image modalities. In sections 2.2.2, we describe in detail TSCF as one specific
instantiation of GNR by showing the implementation of these three primitives that suits DCE-
MRI sequences and discuss in detail the reason behind the implementation decisions for each on
these primitives (e.g. extracting sparsity in gather step incorporating both temporal and spatial
information in DCE-MRI sequence). BM3D/BM4D can be viewed as an instantiation of GNR
that incorporates only spatial information of the image with more exhaustive pixel grouping im-
plementation of gather step that might be suitable for applications with stationary or static image
modalities. Hence, one can formulate new denoising algorithms for different image modalities by
just implementing the GNR primitives.
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5 Conclusion
DCE-MRI is a minimally invasive imaging technique which can be used for characterizing mi-
crovasculature characteristics of normal and cancerous tissues. PK estimation is widely used in
DCE-MRI data analysis to extract quantitative parameters relating to vasculature and tissue hemo-
dynamics. The noise in DCE-MRI data has a large effect on the accuracy of PK estimation. In
this paper, we proposed a 3-stage denoising and PK parameter estimation pipeline for noise cor-
rupted DCE-MRI data. We proposed a general denoising paradigm, gather-noise attenuate-reduce
(GNR), for signal restoration, as well as TSCF, a specially designed algorithm to denoise DCE-
MRI data. TSCF takes advantage of sparsity brought by temporal correlation in DCE-MRI, as well
as anatomical spatial similarity to collaboratively filter noisy DCE-MRI data. We evaluated the
proposed framework with both DRO phantom data and TCIA QIN Breast DCE-MRI dataset.
The proposed TSCF denoising algorithm achieves up to 57% reduction of normalized estimation
error, and up to a 86% improvement in the structural similarity of PK parameter estimation than
the baseline method without denoising, and an order of magnitude faster than the state-of-the-art
denoising method. With TSCF denoising, the ULR c−statistic value for early prediction of patho-
logic response is improved up to 18%. pCRs and non-pCRs in TCIA QIN Breast DCE-MRI
dataset can be 100% completely separated.
In the future, transformation methods other than DCT will be investigated for TSCF. Also,
TSCF will be used as a preprocessing step on noisy DCE-MRI before performing other medical
imaging analysis tasks such as image registration/motion estimation. We will also evaluate TSCF
for other type of medical images with temporal correlation.
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Appendix A:
A.1 MR Noise Review
The MR complex raw data is measured through a quadrature detector resulting in the real and the
imaginary quadrature channels. Taking the magnitude of the complex data results in a nonlinear
mapping between the noise and the true unknown signal. And hence the additive noise from each
quadrature channels is transformed into Rician noise.62 More formally, the magnitude MR signal
z ∼ R(y, σg), has Rician distribution with parameters y ≥ 0 and σg ≥ 0,
z =
√
(y + nr)2 + n2i (29)
where y is the unknown true signal intensity and nr and ni are the noise from the real and com-
plex MR signals with Gaussian distribution of mean zero and standard deviation σg and the noise
variance is assumed to be the same in both the channels .46,63
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Let say the signal-to-noise ratio (SNR) is defined as θ = y
σg
. According to Koay,34 the raw
image standard deviation σr is related to σg as follows:
σ2r = ξ(θ)σ
2
g
(30)
where ξ is a correction factor which is a function of the SNR θ:
ξ(θ) = 2 + θ2 − π
8
× exp(−θ
2
2
)((2 + θ2)I0(
θ2
4
) + θ2I1(
θ2
4
))2
(31)
where In denotes the Modified Bessel function of order n, In(x) =
∑ (x/2)n+2m
m!Γ(n+m+1)
.64
Koay34 further derives a fixed point formula of SNR, that establishes a relationship between
true signal SNR (θ = y
σg
) and magnitude SNR (µm
σm
):
θ =
√
ξ(θ)[1 +
µ2m
σ2m
]− 2 (32)
where µm is first moment (observed mean) of the magnitude DCE-MRI data, σm is the standard
deviation of the magnitude signal. Finally the fixed point solution of SNR can be calculated using
Newton’s method of root finding if the mean and the standard deviation of the magnitude signals
are available.
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Fig 16: Variance Stabilizer.
A.2 Variance Stabilizer
For both VST and IVST step, we use the stabilizer ‘B’ from,35 because compared to stabilizer
‘A’, it approximates ideal stabilizer much better when the ratio of the true signal to the standard
deviation of transformed noisy signal is less than 6, as shown in Figure 16.
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